Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry M Keith

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Vaccine|February 13, 2007
The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTPJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
The Journal of Infectious Diseases|December 14, 2004
The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxinsJohn B Robbins, Rachel Schneerson, Birger Trollfors, et al.
The Pediatric Infectious Disease Journal|January 24, 2009
Pertussis vaccine: a critiqueJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2014
Toward a new vaccine for pertussisJohn B Robbins, Rachel Schneerson, Joanna Kubler-Kielb, et al.
Vaccine|August 19, 2009
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virusZuzana Biesova, Mark A Miller, Rachel Schneerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccineJoanna Kubler-Kielb, Evgeny Vinogradov, Teresa Lagergård, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugatesJoanna Kubler-Kielb, Fathy Majadly, Zuzana Biesova, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vaccine|February 13, 2007
The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTPJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
The Journal of Infectious Diseases|December 14, 2004
The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxinsJohn B Robbins, Rachel Schneerson, Birger Trollfors, et al.
The Pediatric Infectious Disease Journal|January 24, 2009
Pertussis vaccine: a critiqueJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2014
Toward a new vaccine for pertussisJohn B Robbins, Rachel Schneerson, Joanna Kubler-Kielb, et al.
Vaccine|August 19, 2009
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virusZuzana Biesova, Mark A Miller, Rachel Schneerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccineJoanna Kubler-Kielb, Evgeny Vinogradov, Teresa Lagergård, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugatesJoanna Kubler-Kielb, Fathy Majadly, Zuzana Biesova, et al.
Pageof 1